Article
Innovations in RNA therapy for hemophilia
21 Jul 2023
Abstract excerpt
Given the shortcomings of current factor-, nonfactor-, and adeno-associated virus gene-based therapies, the recent advent of RNA-based therapeutics for hemophilia is changing the fundamental approach to hemophilia management. From small interfering RNA therapeutics that knockdown clot regulators antithrombin, protein S, and heparin cofactor II, to CRISPR/Cas9 gene editing that may personalize treatment, improved...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
